Galvusmet 50/850 mg tablets contain a combination of vildagliptin (DPP-4 inhibitor) and metformin (biguanide), two effective agents for controlling type 2 diabetes. Vildagliptin enhances insulin secretion and reduces glucose production, while metformin improves insulin sensitivity and lowers glucose absorption in the intestines. This combination helps maintain stable blood sugar levels throughout the day. It is prescribed for patients who require better glucose control when metformin alone is insufficient. It should be used along with a proper diet and regular physical activity. Regular blood sugar monitoring is recommended to avoid complications. . Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
